The largest database of trusted experimental protocols

4 protocols using sars cov 2 s

1

SARS-CoV-2 Antibody ELISA Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the antibody response against the different SARS-CoV-2 proteins or different fragments of the spike protein, SARS-CoV-2 S (spike protein, 1203 aa), S1 (675 aa), S2 (533 aa), RBD (228 aa) and N (424 aa) proteins were obtained from Sino Biological, Inc (Beijing) and used as coating antigens in our in-house ELISA to detect the antigen-specific IgG. Briefly, 96-well plates (Jet, Biofil Co., Ltd, Guangzhou) were coated with 100 μl/well (0.5 μg/ml) of SARS-CoV-2 S, S1, S2, RBD or N protein in DPBS buffer (Thermo Fisher Scientific (China), Shanghai) overnight at 4°C. After blocking (DPBS, 10%FBS), 100 μl of diluted plasma (1:100) were added and plates were incubated at 37°C for one hour. After washing, plates were incubated with 100 μl of HRP-conjugated mouse anti-human IgG (H+L) antibody (Catalog No: 109-035-088, Jackson ImmunoResearch, West Grove, PA) at 37°C for one hour. Reactions were visualized by adding 50 μl of TMB (3,3’,5,5’-Tetramethylbenzidine) substrate solution (Biohao Biotechnology Co., Ltd., Beijing). Each plate was monitored to have the same reaction time and the optical densities at 450 nm were then read. The mean value of the healthy donor plasma (named HD group) collected in 2017-2018 plus 3 standard deviations was used as the detection threshold.
+ Open protocol
+ Expand
2

SARS-CoV-2 Spike Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
BSRT7 cells were infected with parental rVSV or rVSV expressing SARS-CoV-2 S antigens as described above. At the indicated time postinfection, cell culture medium was harvested and clarified at 5,000 × g for 15 min. In the meantime, cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (catalog no. ab156034; Abcam). Proteins were separated by 12% SDS-PAGE and transferred to a Hybond enhanced chemiluminescence nitrocellulose membrane (Amersham) in a Mini Trans-Blot electrophoretic transfer cell (Bio-Rad). The blot was probed with rabbit anti-SARS-CoV-1 S (catalog no. 40592-T62; Sino Biological), SARS-CoV-2 S (catalog no. 40150-R007; Sino Biological), or RBD (catalog no. 40592-MP01; Sino Biological) antibody at a dilution of 1:2,000, followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (Santa Cruz) at a dilution of 1:5,000. The blot was developed with SuperSignal West Pico chemiluminescent substrate (Thermo Scientific) and exposed to BioMax MR film (Kodak).
+ Open protocol
+ Expand
3

SARS-CoV-2 Antibody ELISA Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples from SARS-CoV-2 infected animals were inactivated by γ-irradiation and used in BSL2 according to IBC-approved SOPs. NUNC Maxisorp Immuno plates were coated with 50 μl of 1 μg/mL of recombinant SARS-CoV-2 S (S1+S2), SARS-CoV-2 RBD (Sino Biological) or EBOV GP (32 (link)) at 4°C overnight and then washed three times with PBS containing 0.05% Tween 20 (PBST). The plates were blocked with 3% skim milk in PBS for 3 hours at room temperature, followed by three additional washes with PBST. The plates were incubated with 50 μl of serial dilutions of the samples in PBS containing 1% skim milk for 1 hour at room temperature. After three washes with PBST, the bound antibodies were labeled using 50 μl of 1:2,500 peroxidase anti-hamster IgG (H+L) (SeraCare Life Sciences) diluted in 1% skim milk in PBST. After incubation for 1 h at room temperature and three washes with PBST, 50 μl of KPL ABTS peroxidase substrate solution mix (SeraCare Life Sciences) was added to each well, and the mixture was incubated for 30 min at room temperature. The optical density (OD) at 405 nm was measured using a GloMax® explorer (Promega) plate reader. The OD values were normalized to the baseline samples obtained with naïve hamster serum and the cutoff value was set as the mean OD plus standard deviation of the blank.
+ Open protocol
+ Expand
4

CTSL Inhibition by Teicoplanin Evaluated

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the CTSL enzymatic activity upon teicoplanin treatment in vitro, the purified 250 ng CTSL proteins (Sino Biological Inc., 10486-H08H, China) were added into the CTSL assay buffer (400 mM NaAc, 4 mM EDTA, 8 mM DTT, and pH 5.5) and incubated in ice for 15 min for CTSL activation. To evaluate the inhibition of teicoplanin on CTSL activity, the purified 250 ng CTSL proteins were also co-incubated with 50 μM teicoplanin (Selleck, S1399, United States). After activation, about 2 μg in vitro purified SARS-CoV S (Sino Biological Inc., 40634-V08B, China) or SARS-CoV-2 S (Sino Biological Inc., 40589-V08B1, China) were added into each group. S protein only group (without CTSL and teicoplanin) was set as control group. The S-CTSL-teicoplanin mixtures were incubated at 37°C for 1.5 h. The enzymatic reaction was stopped by adding with SDS-PAGE loading buffer and followed by boiling at 100°C for 10 min. Digested proteins were proceeded to SDS-PAGE and analyzed by silver staining (Sigma-Aldrich, PROTSIL2-1KT, United States).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!